Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis

Sponsor
Changhai Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03373682
Collaborator
(none)
1,404
1
87.9
16

Study Details

Study Description

Brief Summary

Pancreatic extracorporeal shock wave lithotripsy (P-ESWL) is recommended as the first-line treatment for pancreatic stones. However, how well P-ESWL performs in geriatric patients remains unclear. The investigators aimed to evaluate the safety and efficacy of P-ESWL for geriatric patients with chronic pancreatitis.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This prospective observational study was conducted in patients with painful chronic pancreatitis who underwent P-ESWL. Patients aged over 65 years were included in the geriatric group; patients aged under 65 years who underwent P-ESWL in the same period were assigned to the control group. For investigation of long-term follow-up, the geriatric group were matched with patients from the control group in a 1:1 ratio. The primary outcomes were P-ESWL complications and pain relief. The secondary outcomes included: stone clearance, physical and mental health, quality of life score, and body weight.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1404 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Safety and Efficacy of Extracorporeal Shock Wave Lithotripsy for Geriatric Patients With Chronic Pancreatitis
    Actual Study Start Date :
    Jan 1, 2011
    Actual Primary Completion Date :
    Apr 30, 2016
    Anticipated Study Completion Date :
    Apr 30, 2018

    Outcome Measures

    Primary Outcome Measures

    1. P-ESWL complications [April 30, 2016]

      The complications after P-ESWL. Including post-ESWL pancreatitis, bleeding, infection, steinstrasse, and perforation. The degree of these complications will also be measured.

    2. Pain relief by the end of follow-up period [April 30, 2018]

      Participants will be followed up annually either by return visit or telephone call. Condition of abdominal pain or acute pancreatitis attack during follow-up will be measured. Pain relief at the end of the follow-up period was classified as complete relief (Izbicki pain score≤10) or partial relief (Izbicki pain score >10 after a decrease of >50%)

    Secondary Outcome Measures

    1. Stone clearance as assessed by ERCP performed post-ESWL [April 30, 2016]

      Stone clearance was evaluated at the ERCP performed post-ESWL, with complete clearance defined as clearance of >90% of the main pancreatic duct stone volume, whereas partial clearance was defined as clearance of 50%-90% of the stone volume.

    2. Physical and mental health assessed by SF-36 questionnaire [April 30, 2018]

      Physical and mental health after treatment were assessed according to the scores on the SF-36 questionnaire.

    3. Quality of life score assessed by the patient [April 30, 2018]

      Quality of life score after treatment were assessed by the patient and ranged from 0 to 100, with higher scores indicating a better quality of life.

    4. Body weight [April 30, 2018]

      Body weight after treatment

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with painful chronic pancreatitis and radiopaque stones of ≥5mm.
    Exclusion Criteria:
    • Patients with a suspected or established malignant mass or pancreatic ascites, and pregnant patients.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Changhai Hospital, Second Military Medical University Shanghai China 200433

    Sponsors and Collaborators

    • Changhai Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Zhaoshen Li, Director of Gastroenterology Dept., Changhai Hospital
    ClinicalTrials.gov Identifier:
    NCT03373682
    Other Study ID Numbers:
    • ESWL-01
    First Posted:
    Dec 14, 2017
    Last Update Posted:
    Dec 14, 2017
    Last Verified:
    Dec 1, 2017
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 14, 2017